Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 408.80 billion as of May 16, 2025. Its market cap has increased by 34.10% in one year.

Market Cap

408.80B

Enterprise Value

408.40B

Revenue

139.61B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,443.30

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 408.80B, an increase of 35,469.04%. That is a compound annual growth rate of 27.79%.

Market Cap History

Date	Market Cap	% Change
May 15, 2025	408.34B	-10.07%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	18.48T
HDFC Bank	14.80T
Tata Consultancy Services	12.95T
Bharti Airtel	11.19T
ICICI Bank	10.34T
State Bank of India	7,208.86B
Infosys	6,684.66B
Bajaj Finance	5,700.91B

Market Cap Rankings